Discover 1,900 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Virginia provides numerous opportunities for both healthy volunteers and people with specific medical conditions to participate in paid medical research. Major research centers in Richmond, Virginia Beach, and Norfolk are actively seeking participants, offering access to innovative treatments and advanced care.
Filter
1
Filter results
Results: 1,900
Active & Responsive
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
for
Idiopathic Hypersomnia
Location: Norfolk VA, Huntersville NC, Winter Park FL,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06812078
Phase 2, Recruiting
Active & Responsive
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
Location: Boston MA, Clifton NJ, Richmond VA, Boca Raton FL,
Sponsor: Palette Life Sciences, Inc.
Sex: Male
Age: 18+
Code: NCT06496256
Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: Lebanon NH, Mineola NY, New York NY, Hackensack NJ,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase 1, Phase 2, Recruiting
Active & Responsive
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
for
Colorectal Cancer
Location: Pennington NJ, Philadelphia PA, Newark DE, Baltimore MD,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06562543
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Inorganic Nitrate as a Treatment for ANOCA: NO-ANOCA
for
Coronary Microvascular Dysfunction (CMD),
Location: Charlottesville VA
Sponsor: University of Virginia
Sex: Female
Age: 18+
Code: NCT06948201
Recruiting
New
A Phase 1/1b Study of PRT13722 in Participants With Advanced HR+/HER2- Breast Cancer
for
Breast Cancer, Hormone-receptor-positive Breast Cancer,
Location: Fairfax VA, Tamarac FL, Maumee OH
Sponsor: Prelude Therapeutics Incorporated
Sex: All
Age: 18+
Code: NCT07905001
Phase 1, Recruiting
New
LIFU for Chronic Pain and Generalized Anxiety Disorder
for
Chronic Pain, Generalized Anxiety Disorder
Location: Roanoke VA
Sponsor: Virginia Polytechnic Institute and State University
Sex: All
Age: 18 - 65
Code: NCT07686354
Recruiting
New
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
for
Diabetes Mellitus, Type 2
Location: Arlington VA, Pompano Beach FL, Miami Lakes FL,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT07866066
Phase 3, Recruiting
New
A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.
for
Primary Open - Angle Glaucoma (POAG), Ocular Hypertension (OHT)
Location: Lynchburg VA, Newport Beach CA, Glendale CA
Sponsor: Tavo Biotherapeutics
Sex: All
Age: 18+
Code: NCT07913074
Phase 2, Recruiting
New
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Boston MA, New York NY, Hackensack NJ, Philadelphia PA,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07542704
Phase 1, Recruiting
New
A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant and How They Feel During Treatment
for
Early Breast Cancer, Estrogen Receptor-Positive Breast Cancer,
Location: Quebec, Montreal, Richmond VA, Salem OR
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07827573
Phase 3, Recruiting
New
CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M),